Skip to main content
PreveCeutical Medical logo

PreveCeutical Medical — Investor Relations & Filings

Ticker · PREV ISIN · CA74143C1068 LEI · 96760001OJCSH5MXZ450 CSE Professional, scientific and technical activities
Open in API
Filings indexed 438 across all filing types
Latest filing 2020-11-23 AGM Information
Country CA Canada
Listing CSE PREV

About PreveCeutical Medical

https://www.preveceutical.com/

PreveCeutical Medical Inc. is a health sciences company dedicated to the research and development of innovative options for preventive and curative therapies. The company specializes in utilizing organic and nature identical products, combining scientific rigor with natural sources to benefit health-conscious consumers. Its primary focus is on the preventive health sector, collaborating with partners to bring novel solutions to market.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
AGM Information Classification · 95% confidence The document is a confirmation notice from TSX Trust Company regarding the record and meeting dates for the upcoming Annual General Meeting (AGM) of Preveceutical Medical Inc. It includes details such as the meeting date, record date for voting, classes of securities entitled to vote, and proxy-related material delivery information. The document does not contain the AGM materials themselves, nor does it include financial data or voting results. It is a notice about the AGM logistics, not the AGM presentation or report. Given the short length (1890 characters) and the nature of the content, this fits best as an AGM Information announcement (AGM-R).
2020-11-23 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the filing of a provisional patent application related to a COVID-19 formulation by PreveCeutical Medical Inc. It contains no financial data, no regulatory filings, no management or board changes, no voting results, no earnings or annual reports, and no detailed financial or operational disclosures. It is primarily an announcement of a patent filing and related forward-looking statements. The content does not fit into any specific financial or regulatory filing categories such as Annual Report, Earnings Release, or Management Reports. It is a general corporate announcement about intellectual property and research progress. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements that do not fit other categories.
2020-11-23 English
News release - English.pdf
Regulatory Filings
2020-11-10 English
News release - English.pdf
Regulatory Filings
2020-10-29 English
News release - English.pdf
Regulatory Filings
2020-10-09 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of Dr. Ajit Shetty as an advisor and consultant to PreveCeutical Medical Inc. It contains no financial statements, no regulatory form references, no voting results, no capital changes, no earnings data, and no detailed management or board information beyond the appointment announcement. The content is primarily a management announcement regarding a senior advisor appointment. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is 8067 characters, which is sufficient for a detailed announcement but does not contain financial or regulatory report data.
2020-10-01 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.